Suʻesuʻega alualu i luma i luga o le enzymatic faʻapipiʻi o mea e mafai ona faʻatupuina o le Clenbuterol i le galulue faʻatasi i le va o Norwegian Iunivesite o Saienisi ma Tekinolosi ma Shangke Biomedical

Clenbuterol, o se β2-adrenergic agonist (β2-adrenergic agonist), e tutusa ma le ephedrine (Ephedrine), e masani ona faʻaaogaina ile falemaʻi e togafitia ai faʻamaʻi faʻamaʻi faʻamaʻi faʻamaʻi (COPD), E faʻaaogaina foi e avea o se bronchodilator e faʻamalolo ai faʻamaʻi ogaoga o le sela.I le amataga o le 1980s, na faʻafuaseʻi ona iloa e le kamupani Amerika Cyanamid o loʻo i ai aʻafiaga manino o le faʻaleleia o le tuputupu aʻe, faʻaleleia le fua o aano o manufasi ma faʻaitiitia le gaʻo, o lea na faʻaaogaina ai le clenbuterol i le fagafao manu.Ae ui i lea, ona o ona aʻafiaga, na faʻasaina ai e le European Community le faʻaaogaina o le clenbuterol e avea o se meaʻai faaopoopo talu mai Ianuari 1, 1988. Na faʻasaina e le FDA i le 1991. I le 1997, na matua faʻasaina e le Matagaluega o Faatoaga a le Malo o Saina. le faʻaogaina o hormones beta-adrenergic i meaʻai ma le gaosiga o manu, ma Clenbuterol hydrochloride tulaga muamua.

Ae ui i lea, racemic Clenbuterol talu ai nei na faʻaalia e faʻaitiitia ai le lamatiaga o le maʻi o Parkinson.Ina ia faʻamaonia poʻo fea (poʻo uma) isomers e maua ai lenei aafiaga, o le Clenbuterol enantiomer mama e tatau ona suʻesuʻeina eseese.